Atomistry » Magnesium » PDB 6mxo-6n7i » 6n2j
Atomistry »
  Magnesium »
    PDB 6mxo-6n7i »
      6n2j »

Magnesium in PDB 6n2j: Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C

Protein crystallography data

The structure of Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C, PDB code: 6n2j was solved by G.P.Vigers, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.84 / 1.80
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 40.250, 51.130, 90.120, 90.00, 90.00, 90.00
R / Rfree (%) 13 / 20.4

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C (pdb code 6n2j). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C, PDB code: 6n2j:

Magnesium binding site 1 out of 1 in 6n2j

Go back to Magnesium Binding Sites List in 6n2j
Magnesium binding site 1 out of 1 in the Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Tetrahydropyridopyrimidines As Covalent Inhibitors of Kras-G12C within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg202

b:21.9
occ:1.00
O2B A:GDP201 2.0 20.1 1.0
O A:HOH312 2.1 19.9 1.0
O A:HOH343 2.1 19.5 1.0
O A:HOH325 2.1 20.2 1.0
OG A:SER17 2.1 20.4 1.0
O A:HOH374 2.2 19.0 1.0
CB A:SER17 3.2 21.6 1.0
PB A:GDP201 3.3 22.4 1.0
O1B A:GDP201 3.6 22.1 1.0
O1A A:GDP201 4.0 25.6 1.0
N A:SER17 4.0 19.9 1.0
OD2 A:ASP57 4.1 24.3 1.0
CA A:SER17 4.2 23.5 1.0
CD1 A:TYR32 4.2 26.5 1.0
OD1 A:ASP57 4.2 23.3 1.0
O3A A:GDP201 4.3 22.2 1.0
O A:ASP33 4.4 26.0 1.0
CB A:ALA59 4.4 23.4 1.0
O3B A:GDP201 4.4 21.3 1.0
CA A:PRO34 4.4 26.2 1.0
PA A:GDP201 4.5 24.1 1.0
O A:THR58 4.6 21.6 1.0
O29 A:K9M203 4.6 25.3 1.0
CG A:ASP57 4.6 22.9 1.0
CE1 A:TYR32 4.6 27.1 1.0
O A:ILE36 4.7 25.2 1.0
O A:TYR32 4.7 32.6 1.0
O A:PRO34 4.8 31.3 1.0
O2A A:GDP201 4.8 21.2 1.0
C A:PRO34 4.9 28.7 1.0
CB A:LYS16 4.9 18.7 1.0
NZ A:LYS16 5.0 22.3 1.0
CE A:LYS16 5.0 19.5 1.0

Reference:

J.B.Fell, J.P.Fischer, B.R.Baer, J.Ballard, J.F.Blake, K.Bouhana, B.J.Brandhuber, D.M.Briere, L.E.Burgess, M.R.Burkard, H.Chiang, M.J.Chicarelli, K.Davidson, J.J.Gaudino, J.Hallin, L.Hanson, K.Hee, E.J.Hicken, R.J.Hinklin, M.A.Marx, M.J.Mejia, P.Olson, P.Savechenkov, N.Sudhakar, T.P.Tang, G.P.Vigers, H.Zecca, J.G.Christensen. Discovery of Tetrahydropyridopyrimidines As Irreversible Covalent Inhibitors of Kras-G12C with in Vivo Activity. Acs Med Chem Lett V. 9 1230 2018.
ISSN: ISSN 1948-5875
PubMed: 30613331
DOI: 10.1021/ACSMEDCHEMLETT.8B00382
Page generated: Tue Oct 1 12:23:52 2024

Last articles

Cl in 3UMG
Cl in 3UMY
Cl in 3UMR
Cl in 3UMS
Cl in 3UMC
Cl in 3UMJ
Cl in 3UMB
Cl in 3UKL
Cl in 3UM8
Cl in 3UKF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy